45
Participants
Start Date
May 31, 2011
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
PM01183 1 mg Powder for concentrate for solution for infusion and PM01183 4 mg Powder for concentrate for solution for infusion
"PM01183 Drug Product will be provided as a lyophilized powder for concentrate for solution for infusion with a strength of 1.0 mg/vial and 4.0 mg/vial.~Before use, the vials will be reconstituted with 2 ml or 8 ml of sterile water for injection to give a solution containing 0.5 mg/ml of PM01183."
Rochester
Houston
Lead Sponsor
PharmaMar
INDUSTRY